Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging SARS-CoV-2 variants of concern and potential intervention approaches
Jasmin Khateeb, Yuchong Li, Haibo Zhang
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 228

Showing 1-25 of 228 citing articles:

Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis
Stella Talic, Shivangi Shah, Holly Wild, et al.
BMJ (2021), pp. e068302-e068302
Open Access | Times Cited: 632
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
Laura Vangeel, Winston Chiu, Steven De Jonghe, et al.
Antiviral Research (2022) Vol. 198, pp. 105252-105252
Open Access | Times Cited: 384
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 206
How the coronavirus infects cells — and why Delta is so dangerous
Megan Scudellari
Nature (2021) Vol. 595, Iss. 7869, pp. 640-644
Closed Access | Times Cited: 161
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
Li Guo, Geng Wang, Yeming Wang, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 5, pp. e348-e356
Open Access | Times Cited: 148
SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
Suresh Thakur, Shalitha Sasi, Sindhu Gopinathan Pillai, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 133
SARS‐CoV‐2 variants and vulnerability at the global level
Vivek P. Chavda, Aayushi Patel, Darsh D. Vaghasiya
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2986-3005
Open Access | Times Cited: 108
COVID‐19 in children. II: Pathogenesis, disease spectrum and management
Annaleise R. Howard‐Jones, David Burgner, Nigel Crawford, et al.
Journal of Paediatrics and Child Health (2021) Vol. 58, Iss. 1, pp. 46-53
Open Access | Times Cited: 104
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern
Hikmet Akkız
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 82
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 69
An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 43
SARS-CoV-2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals
Sizhu Amelia Chen, Elena Arutyunova, Jimmy Lu, et al.
ACS Central Science (2023) Vol. 9, Iss. 4, pp. 696-708
Open Access | Times Cited: 43
Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort
Gerald Kevin Oluka, Jackson Sembera, Joseph Ssebwana Katende, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 143-143
Open Access | Times Cited: 1
High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines
Kathryn A. Pape, Thamotharampillai Dileepan, Amanda J. Kabage, et al.
Cell Reports (2021) Vol. 37, Iss. 2, pp. 109823-109823
Open Access | Times Cited: 92
Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms
Damariz Marín-Palma, Jorge H. Tabares-Guevara, María I. Zapata-Cardona, et al.
Molecules (2021) Vol. 26, Iss. 22, pp. 6900-6900
Open Access | Times Cited: 85
Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
Swarnali Das, Suvrendu Sankar Kar, Sovan Samanta, et al.
Immunologic Research (2022) Vol. 70, Iss. 3, pp. 289-315
Open Access | Times Cited: 64
COVID-19 Diagnosis: A Comprehensive Review of the RT-qPCR Method for Detection of SARS-CoV-2
Debashis Dutta, Sarah Naiyer, Sabanaz Mansuri, et al.
Diagnostics (2022) Vol. 12, Iss. 6, pp. 1503-1503
Open Access | Times Cited: 64
The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
Pedro F.N. Souza, Felipe Pantoja Mesquita, Jackson L. Amaral, et al.
International Journal of Biological Macromolecules (2022) Vol. 208, pp. 105-125
Open Access | Times Cited: 59
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies
Wenping Gong, Seppo Parkkila, Xueqiong Wu, et al.
International Reviews of Immunology (2022) Vol. 42, Iss. 6, pp. 393-414
Open Access | Times Cited: 59
Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients
Zhenkui Hu, Xing Huang, Jianguo Zhang, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 58
Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination
Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 8, pp. 1372-1381
Open Access | Times Cited: 56
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
Cai He, H. J. Yang, Weiqi Hong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro
Senem Merve Fred, Suvi Kuivanen, Hasan Uğurlu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 51
Coronavirus Infection and Cholesterol Metabolism
Jun Dai, Huan Wang, Ying Liao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview
Anamika Gupta, Hezlin Marzook, Firdos Ahmad
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 2, pp. 313-331
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top